SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Clinical trials for SYSTEM LUPUS ERYTHEMATOSUS(SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear
Sign up with your email to follow new studies for SYSTEM LUPUS ERYTHEMATOSUS(SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug combo enters first human tests
Disease control Not yet recruitingThis early study tests a new drug called YKST02, given alone or with another drug (YK012), in 30 adults with active or hard-to-treat lupus. The main goal is to see if the treatment is safe and tolerable. Researchers will also look for early signs that it helps control the disease…
Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
Donor cells take on lupus in new trial
Disease control Not yet recruitingThis study tests a new treatment called ACE1831 for people with lupus that is active despite standard therapies. ACE1831 uses immune cells from healthy donors to try to control the disease. The study will check if the treatment is safe and if it reduces lupus symptoms. It involve…
Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 03:01 UTC